Eric Lacoste

440 total citations
8 papers, 295 citations indexed

About

Eric Lacoste is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Eric Lacoste has authored 8 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Eric Lacoste's work include Toxin Mechanisms and Immunotoxins (2 papers), Beetle Biology and Toxicology Studies (1 paper) and Mast cells and histamine (1 paper). Eric Lacoste is often cited by papers focused on Toxin Mechanisms and Immunotoxins (2 papers), Beetle Biology and Toxicology Studies (1 paper) and Mast cells and histamine (1 paper). Eric Lacoste collaborates with scholars based in France, United States and Japan. Eric Lacoste's co-authors include Henry Lai, Tomikazu Sasaki, Ikuhiko Nakase, Narendra P. Singh, Byron Gallis, David R. Goodlett, Christophe Chartier, M. Alvinerie, J.F. Sutra and Shiroh Futaki and has published in prestigious journals such as Cancer Letters, Veterinary Parasitology and Biomolecules.

In The Last Decade

Eric Lacoste

8 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Lacoste France 7 129 52 51 37 33 8 295
Vinay Kumar Venishetty India 7 144 1.1× 45 0.9× 55 1.1× 37 1.0× 99 3.0× 15 428
Pradeep Sharma India 10 142 1.1× 16 0.3× 7 0.1× 68 1.8× 8 0.2× 37 425
In Seok Yang South Korea 14 325 2.5× 10 0.2× 31 0.6× 88 2.4× 7 0.2× 25 579
Arshpreet Kaur India 8 119 0.9× 16 0.3× 5 0.1× 26 0.7× 18 0.5× 23 315
Irma Herrera‐Camacho Mexico 12 172 1.3× 65 1.3× 4 0.1× 112 3.0× 8 0.2× 38 510
Nora Hilda Rosas-Murrieta Mexico 13 284 2.2× 47 0.9× 5 0.1× 68 1.8× 6 0.2× 37 577
Heguo Yu China 14 360 2.8× 72 1.4× 3 0.1× 39 1.1× 12 0.4× 25 582
Mohammad Reza Akbari Eidgahi Iran 12 198 1.5× 24 0.5× 5 0.1× 24 0.6× 18 0.5× 28 392
Muzamil Y. Want India 14 114 0.9× 212 4.1× 6 0.1× 60 1.6× 27 0.8× 19 492

Countries citing papers authored by Eric Lacoste

Since Specialization
Citations

This map shows the geographic impact of Eric Lacoste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lacoste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lacoste more than expected).

Fields of papers citing papers by Eric Lacoste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Lacoste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lacoste. The network helps show where Eric Lacoste may publish in the future.

Co-authorship network of co-authors of Eric Lacoste

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Lacoste. A scholar is included among the top collaborators of Eric Lacoste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Lacoste. Eric Lacoste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Clement, Emily, Muriel Blanzat, Cédric‐Olivier Turrin, et al.. (2020). An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis. Biomolecules. 10(6). 949–949. 15 indexed citations
2.
Gallis, Byron, David R. Goodlett, Yi Yang, et al.. (2013). Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.. Anticancer Research. 33(1). 123–32. 33 indexed citations
3.
Kovalchin, Joseph, Jeffrey Krieger, Tony Avril, et al.. (2010). Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(5). 649–660. 8 indexed citations
4.
Lai, Henry, Ikuhiko Nakase, Eric Lacoste, Narendra P. Singh, & Tomikazu Sasaki. (2009). Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.. Anticancer Research. 29(10). 3807–10. 57 indexed citations
5.
Nakase, Ikuhiko, Byron Gallis, Tomoka Takatani‐Nakase, et al.. (2008). Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Letters. 274(2). 290–298. 117 indexed citations
6.
Lacoste, Eric, et al.. (2007). Pharmacokinetics of metaflumizone in the plasma and hair of cats following topical application. Veterinary Parasitology. 150(3). 258–262. 1 indexed citations
7.
Lacoste, Eric, et al.. (2007). Pharmacokinetics of metaflumizone and amitraz in the plasma and hair of dogs following topical application. Veterinary Parasitology. 150(3). 251–257. 8 indexed citations
8.
Alvinerie, M., Eric Lacoste, J.F. Sutra, & Christophe Chartier. (1999). Some Pharmacokinetic Parameters of Eprinomectin in Goats following Pour-on Administration. Veterinary Research Communications. 23(7). 449–455. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026